-
Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market -
FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine -
GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback -
GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall -
GSK Says FDA Approves Kidney Disease Drug for Children -
Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off -
GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead -
GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets -
Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO -
GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi -
EU Signs Deal With GSK for Supply of Potential COVID-19 Drug -
Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK -
Drugmaker GSK to Eliminate 650 US Jobs -
British Private Eye in China Prosecuted for Knowing Too Much